Skip to content
Peptides Codex

Use the arrow keys to choose a result, Enter to open it, and Escape to close.

← Home
Hormone

ACTH

ACTH (adrenocorticotropic hormone) is a 39-amino-acid pituitary hormone that drives adrenal cortisol release. As a key node of the HPA stress axis, it is a foundational peptide in endocrinology.

By The Peptides Codex Editorial TeamIndividual review date not recorded

Page data last changed: . Chemistry registry snapshot: . Registry refreshes and identity assessments are separate from scientific content review.

Length
39 aa
Class
Hormone
Function
Stimulates adrenal cortisol production
Context
Endocrine diagnostics and research (approved forms exist)

Central hormone of the hypothalamic–pituitary–adrenal (HPA) axis.

Also known as: Adrenocorticotropic hormone · Corticotropin

Part of the Foundational & therapeutic peptides cluster

Overview

ACTH (adrenocorticotropic hormone) is a 39-amino-acid pituitary hormone that drives adrenal cortisol release. As a key node of the HPA stress axis, it is a foundational peptide in endocrinology.

Source & context

Biological / chemical source: Anterior pituitary; derived from proopiomelanocortin (POMC)

Primary research or clinical context: Endocrine diagnostics and research (approved forms exist)

HPA-axis role

ACTH is released in response to hypothalamic CRH and stimulates the adrenal cortex to produce cortisol. Its first 24 residues carry the biological activity, a fact reflected in synthetic fragments used in endocrine testing.

Shared POMC origin

ACTH is cleaved from proopiomelanocortin, the same precursor that yields alpha-MSH and beta-endorphin. This shared origin explains overlapping sequence motifs across these peptides.

Sequence

One-letter sequence commonly cited for ACTH (educational; isoforms and modifications may differ):

SYSMEHFRWGKPVGKKRRPVKVYPNGAEDESAEAFPLEF

SYSMEHFRWGKPVGKKRRPVKVYPNGAEDESAEAFPLEF

ACTH39 aa · C207H308N56O58S · ≈ 4,541 DaPEPTIDESCODEX.COMN-terminus →→ C-terminusS1Y2S3M4E−5H6F7R+8W9G10K+11P12V13G14K+15K+16R+17R+18P19V20K+21V22Y23P24N25G26A27E−28D−29E−30S31A32E−33A34F35P36L37E−38F39nonpolarpolaracidicbasicGly / Pronon-canonical (X)Hydropathy (Kyte–Doolittle): ▮ hydrophobic (cyan) / ▮ hydrophilic (rose) · Side-chain charge at pH 7: + / −
ACTH — Structure cardDownload SVG
S1Y2S3M4E5H6F7R8W9G10K11P12V13G14K15K16R17R18P19V20K21V22Y23P24N25G26A27E28D29E30S31A32E33A34F35P36L37E38F39
Helical wheel projection

Residues plotted ~100° apart around an α-helix — clustering of one color reveals an amphipathic face.

Analyze sequences in the playground →

Structure & chemistry

Molecular identity & reference confidence

Source-supported reference

Reference values are taken from the cited molecular record or curated profile. A database match is not independent laboratory verification; modifications, counter-ions, and formulations can change the measured mass.

Molecular form
ACTH (source record; form not independently established)
Species
Not established by this molecular identity audit
Termini (N / C)
Not specified / Not specified

Average reference mass

Reference policy updated: 2026-10-05

Molecular formula
C207H308N56O58S
Average reference mass
≈ 4,541
Identifiers

Chemistry values: PubChem, IUPHAR/BPS Guide to Pharmacology · fetched 2026-10-01.

Clinical development snapshot

ClinicalTrials.gov lists 346 registered studies with “ACTH” as an intervention (snapshot 2026-10-01). A registry footprint is not evidence of efficacy or approval.

Registered studies
346
Highest phase reached
Phase 4
Active in latest 100
49
Most recent update
2026-10-01
Most recently updated studies
NCTTitlePhaseStatusUpdated
NCT06399874Nightmare Deconstruction and Reprocessing vs. NightWare WristbandPhase 2active not recruiting2026-10-01
NCT00005927Study of Adrenal Gland Tumors—completed2026-09-28
NCT07833163Corticotropin for Behçet's Disease: A Multicenter Randomized Controlled TrialAcronym.Phase 2not yet recruiting2026-09-22
NCT05907291Evaluate the Safety, Efficacy, and Pharmacokinetics of CRN04894 in Participants With Congenital Adrenal HyperpPhase 2completed2026-09-10
NCT01367964Prevention of West Syndrome With Low-dose Adrenocorticotropin Hormone (ACTH)Not applicableterminated2026-09-09
NCT07811089Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of OMS1620Phase 1not yet recruiting2026-09-09
See all on ClinicalTrials.gov →
Concentration math

ACTH — reconstitution calculator

Enter how much peptide is in the vial and how much diluent (e.g. bacteriostatic water) is added. The tool returns the resulting solution concentration — and, for any amount you type, the volume it corresponds to. This is educational arithmetic, not a dosing recommendation.

Reference form: ACTH (source record; form not independently established)Average reference mass: 4,541 Da

Syringe graduation
Solution concentration
5 mg/mL5,000 mcg/mL
mcg

Enter an amount to see the volume it corresponds to.

Educational concentration mathematics only. This tool does not recommend a dose, amount, or protocol, and nothing here is medical advice. Many peptides are not authorized by Health Canada for human use — see our reconstitution and bacteriostatic-water guides for context.

Open the ACTH calculator on its own page →

Change log

Dated observations from the data pipeline (registry flags, trial footprints, identifiers) and editorial reviews of this profile.

  1. Trials2 registered studies added on ClinicalTrials.gov (now 346).

FAQ about ACTH

What is ACTH?+

ACTH (adrenocorticotropic hormone) is a 39-amino-acid pituitary hormone that drives adrenal cortisol release. As a key node of the HPA stress axis, it is a foundational peptide in endocrinology.

What Canadian product status is recorded for ACTH?+

Canadian product status for ACTH has not been verified in this profile. No verified record here does not mean no authorization exists. Status depends on the product, formulation and use; consult Health Canada's product records.

What is the typical length of ACTH?+

ACTH is commonly described as approximately 39 amino acids (Hormone).

Related peptides

References & further reading

  1. 1.Suda (1989). Adrenocorticotropic hormone (ACTH). Jpn J Med
  2. 2.Nasushita (2005). [Adrenocorticotropic hormone (ACTH)]. Nihon Rinsho
  3. 3.Yalow (1976). Multiple forms of corticotropin (adrenocorticotropic hormone, ACTH) and their significance. Ciba Found Symp
  4. 4.Gonzalez-Heydrich et al. (2001). Corticotropin releasing hormone increases apparent potency of adrenocorticotropic hormone stimulation of cortisol secretion. Med Hypotheses
  5. 5.Crane et al. (2020). Use of Adrenocorticotropic Hormone in Ophthalmology. J Ocul Pharmacol Ther
  6. 6.Makara (1992). The relative importance of hypothalamic neurons containing corticotropin-releasing factor or vasopressin in the regulation of adrenocorticotropic hormone secretion. Ciba Found Symp
  7. 7.Guia Lopes et al. (2023). A Rare Cause of Cushing's Syndrome: an Adrenocorticotropic Hormone (ACTH)-Secreting Pheochromocytoma. Cureus
  8. 8.Chen et al. (2021). Vagus nerve stimulation suppresses corticotropin-releasing factor-induced adrenocorticotropic hormone release in rats. Neuroreport
  9. 9.PubChem — compound summary for Corticotropin / ACTH (CID 16132265)
  10. 10.Wikipedia — Adrenocorticotropic hormone
Disclaimer: Educational content only. Not medical advice. Not instructions for human use. Research peptides and unapproved products may be restricted or illegal to market for human consumption in your jurisdiction. Consult qualified professionals and applicable law.
You might also like: All peptides · Atlas · Research · Tools
Cite this: Peptides Codex — ACTH educational profile.
Tip: Use browser print (Ctrl/Cmd + P) for a clean PDF of this page.